DSGN
Design Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Pratik Shah
IPO Date
2021-03-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Design Therapeutics, Inc.
CEO
Pratik Shah
IPO Date
2021-03-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 30,000 |
| $10.55 |
| 11 Jun 2026 | LAPPE RODNEY W | director | A-Award | Acquired | 30,000 | $10.55 |
| 11 Jun 2026 | Gover Justin D. | director | A-Award | Acquired | 30,000 | $10.55 |
| 11 Jun 2026 | Shapiro David | director | A-Award | Acquired | 30,000 | $10.55 |
| 11 Jun 2026 | Berger Heather A. | director | A-Award | Acquired | 30,000 | $10.55 |
| 1 Apr 2026 | Shapiro David | director | A-Award | Acquired | 60,000 | $10.64 |
| 1 Apr 2026 | Shapiro David | director | A-Award | Acquired | 7,500 | $10.64 |
| 1 Apr 2026 | Shapiro David | — | Disposed | 0 | $0.00 |
| 5 Jan 2026 | Storgard Chris | Chief Medical Officer | A-Award | Acquired | 250,000 | $9.10 |